Advertisement

Topics

ShoeWow, Specialist in Footwear for Plantar Fasciitis, Finds That Hope is on the Horizon for Heel Pain Sufferers

03:45 EDT 22 Aug 2017 | PR.com

Marietta, GA, August 22, 2017 --(PR.com)-- Approximately 1 in 10 Americans will suffer from plantar fasciitis during their lives, making it the most common cause of foot pain and heel pain. The only options for treatment are pain relief for the symptoms, or corrective surgery that doesn’t offer a lifetime cure. A company called Mimedx has brought hope to the millions who suffer this condition globally; their AmnioFix drug has passed phase 2B of clinical trials, and is only step away from being made readily available.

The Plantar Fascia is the tissue that runs underneath the foot. Plantar Fasciitis is the thickening of this wall, and can be caused by a series of minor injuries. It is sometimes referred to as jogger’s heel, because it is most common in long distance runners. However, professionals like nurses and policemen, who spend a lot of their time on their feet, are also more prone to this condition.

Symptoms include inflammation of the foot, and a sharp, stabbing pain in the heel. These symptoms are most likely to occur in the morning and also following exercise.

Current treatment for this condition typically means treating the pain and other symptoms. Anti-inflammatory drugs and pain killers are commonly used. Splints may also be worn overnight, which relieve some of the pressure on the plantar and the rest of the heel. Surgery may be considered, if a patient’s pain is acute or they have suffered the condition for many years, but this doesn’t offer a long-term solution either. The problem will usually resurface after years or even months.

AmnioFix uses cells that are removed from the amniotic membrane that surrounds a child. This membrane is usually discarded after birth, and the collection of the tissue is ethical, pain free, and does not cause complications. It is collected from willing donors that give birth using caesarean section.

Matt Jackson, of ShoeWow.com, who specialises in providing information on plantar fasciitis shoes and footwear for other common health complaints, welcomed the possibility of a more effective long-term solution to what is a common foot complaint. “Sufferers have very few options for managing pain, and no options for the long-term relief of the problem. Drugs can relieve the pain, while choosing the right shoe and combining this with a supportive shoe insert can help relieve a lot of the pressure when playing sports, walking, or standing around all day, but, if the final trials are successful, AmnioFix could bring lifelong relief for a very painful condition.”

Contact Information:
ShoeWow
Matt Jackson
(+44)7450914222
Contact via Email
http://shoewow.com/
Prefer to be contacted by email.

Read the full story here: http://www.pr.com/press-release/727409

Press Release Distributed by PR.com

Original Article: ShoeWow, Specialist in Footwear for Plantar Fasciitis, Finds That Hope is on the Horizon for Heel Pain Sufferers

NEXT ARTICLE

More From BioPortfolio on "ShoeWow, Specialist in Footwear for Plantar Fasciitis, Finds That Hope is on the Horizon for Heel Pain Sufferers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...